Karuna Therapeutics (NASDAQ:KRTX) Rating Reiterated by JMP Securities
JMP Securities restated their market outperform rating on shares of Karuna Therapeutics (NASDAQ:KRTX – Get Rating) in a report released on Tuesday morning, Benzinga reports. JMP Securities currently has a $323.00 target price on the stock. A number of other equities analysts have also commented on the stock. Mizuho decreased their price objective on shares […]